Cargando…
Role of biomarkers in risk stratification of acute coronary syndrome
Diagnosis of acute coronary syndrome (ACS) encompasses a wide spectrum of myocardial ischaemia varying from assuredly benign to potentially fatal. Cardiac biomarkers have had a major impact on the management of this disease and are now the cornerstone in its diagnosis and prognosis. In this review w...
Autores principales: | Nagesh, C.M., Roy, Ambuj |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028962/ https://www.ncbi.nlm.nih.gov/pubmed/21150016 http://dx.doi.org/10.4103/0971-5916.73419 |
Ejemplares similares
-
The role of biomarkers in the diagnosis and risk stratification of acute coronary syndrome
por: Chacko, Sanoj, et al.
Publicado: (2017) -
Risk Stratification of Patients with Acute Coronary Syndrome
por: Bauer, Dávid, et al.
Publicado: (2021) -
Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
por: Eggers, K. M., et al.
Publicado: (2017) -
The Serum Metabolic Biomarkers in Early Diagnosis and Risk Stratification of Acute Coronary Syndrome
por: Jiang, Huali, et al.
Publicado: (2020) -
The Incremental Value of Troponin Biomarkers in Risk Stratification of Acute Coronary Syndromes: Is the Relationship Multiplicative?
por: Amin, Amit P, et al.
Publicado: (2009)